Zealand Pharma A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Zealand Pharma A/S generated cash of -$1,211,971,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,332,751,000 last year. Net change in cash is therefore $168,882,000.
Cash Flow
| 2012 | 68.53M | 13.44M | 0 |
|---|---|---|---|
| 2013 | -169.61M | 96.80M | 0 |
| 2014 | -42.18M | 19.76M | 272.17M |
| 2015 | -225.41M | -4.01M | 96.41M |
| 2016 | 40.90M | -299.95M | 157.14M |
| 2017 | -278.74M | 221.35M | 337.93M |
| 2018 | -460.4M | 881.90M | -155.44M |
| 2019 | -409.45M | -51.66M | 674.48M |
| 2020 | -688.71M | -196.80M | 760.94M |
| 2021 | -1.21B | -18.12M | 1.33B |
ZEAL Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 960.22M | 1.08B | 860.63M | 588.71M | 323.33M | 418.79M | 538.27M | 286.17M | 358.84M | 278.34M |
Operating activities | ||||||||||
Net income | -1.01B | -846.72M | -571.54M | 581.28M | -272.27M | -153.91M | -113.95M | -64.99M | -183.67M | 36.37M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 40.24M | 42.69M | 13.68M | 4.50M | 4.75M | 5.41M | 6.21M | 5.93M | 5.91M | 5.31M |
Stock-based compensation expense | 53.50M | 30.48M | 14.76M | 17.46M | 20.15M | 22.72M | 16.94M | 1.67M | 8.80M | 13.24M |
| Deferred income tax benefit | 53.50M | 30.48M | 14.76M | 17.46M | 20.15M | 22.72M | 16.94M | 1.67M | 8.80M | 13.24M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.44M | 0 |
Inventories | -52.77M | -14.40M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 805K | 0 |
Cash generated by operating activities | -1.21B | -688.71M | -409.45M | -460.4M | -278.74M | 40.90M | -225.41M | -42.18M | -169.61M | 68.53M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -22.80M | -299.84M | -84.34M | 0 | 0 | 0 | -47.35M | -97.48M |
Investments In Property Plant And Equipment | -22.13M | -25.04M | -23.51M | -4.03M | -7.22M | -2.6M | -4.04M | -4.49M | -4.56M | -8.84M |
Acquisitions Net | 0 | -167.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -18.12M | -196.80M | -51.66M | 881.90M | 221.35M | -299.95M | -4.01M | 19.76M | 96.80M | 13.44M |
Financing activities | ||||||||||
Common Stock Issued | 748.97M | 791.50M | 645.14M | 0 | 567.07M | 135.21M | 96.41M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -28.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -14.71M | -29.21M | 0 | -158.31M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.33B | 760.94M | 674.48M | -155.44M | 337.93M | 157.14M | 96.41M | 272.17M | 0 | 0 |
Net Change In Cash | 168.88M | -120.83M | 220.42M | 271.91M | 265.38M | -95.46M | -98.07M | 252.09M | -72.66M | 80.58M |
Cash at end of period | 1.12B | 960.22M | 1.08B | 860.63M | 588.71M | 323.33M | 440.19M | 538.27M | 286.17M | 358.92M |
| Data source | Data source | Data source | Data source | Data source |